| http://dbpedia.org/ontology/abstract
|
Louis Anthony Tartaglia is an American bio … Louis Anthony Tartaglia is an American biochemist, pharmaceutical scientist, and entrepreneur. As a scientist, he is known for first identifying and cloning the leptin receptor in 1995, a discovery that prompted immediate coverage in US national media given its expected clinical significance. He is also known for studying signaling mechanisms from the tumor necrosis factor (TNF) receptors, and for publishing studies in the fields of obesity and diabetes which are often discussed in subject reviews. After moving from academia to industry in 1990, for over a decade he accompanied the growth of Millennium Pharmaceuticals, reaching top positions within the company. From executive roles he has occupied in venture capital firms, and as a member of several advisory boards, Tartaglia has helped start a number of therapeutics oriented companies that have found their way into the market, among them Agios, Editas, Rhythm, and Zafgen. Tartaglia was born in Albany, New York in 1963.glia was born in Albany, New York in 1963.
|
| http://dbpedia.org/ontology/wikiPageID
|
65297374
|
| http://dbpedia.org/ontology/wikiPageLength
|
14299
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1107967193
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Genentech +
, http://dbpedia.org/resource/David_Goeddel +
, http://dbpedia.org/resource/TNF +
, http://dbpedia.org/resource/Long-chain_fatty_acid_transport_protein_4 +
, http://dbpedia.org/resource/Mitochondrion +
, http://dbpedia.org/resource/UC_Berkeley +
, http://dbpedia.org/resource/UCP2 +
, http://dbpedia.org/resource/Editas_Medicine +
, http://dbpedia.org/resource/Category:People_from_Albany%2C_New_York +
, http://dbpedia.org/resource/Whitehead_Institute +
, http://dbpedia.org/resource/Beaverton%2C_Oregon +
, http://dbpedia.org/resource/Category:American_biochemists +
, http://dbpedia.org/resource/Category:University_of_California%2C_Berkeley_alumni +
, http://dbpedia.org/resource/Cell_Journal +
, http://dbpedia.org/resource/Category:1963_births +
, http://dbpedia.org/resource/Leptin +
, http://dbpedia.org/resource/Prague +
, http://dbpedia.org/resource/Oxidative_stress +
, http://dbpedia.org/resource/Agios_Pharmaceuticals +
, http://dbpedia.org/resource/Science_%28journal%29 +
, http://dbpedia.org/resource/UCP3 +
, http://dbpedia.org/resource/Category:Scientists_from_New_York_%28state%29 +
, http://dbpedia.org/resource/Bruce_Ames +
, http://dbpedia.org/resource/Category:Living_people +
, http://dbpedia.org/resource/Melanocortin_4_receptor +
, http://dbpedia.org/resource/Takeda_Oncology +
, http://dbpedia.org/resource/Tumor_necrosis_factor +
, http://dbpedia.org/resource/Systematic_review +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Authority_control +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:American_biochemists +
, http://dbpedia.org/resource/Category:1963_births +
, http://dbpedia.org/resource/Category:University_of_California%2C_Berkeley_alumni +
, http://dbpedia.org/resource/Category:Scientists_from_New_York_%28state%29 +
, http://dbpedia.org/resource/Category:Living_people +
, http://dbpedia.org/resource/Category:People_from_Albany%2C_New_York +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Louis_Tartaglia?oldid=1107967193&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Louis_Tartaglia +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q101111665 +
, http://dbpedia.org/resource/Louis_Tartaglia +
, https://global.dbpedia.org/id/FLLwf +
|
| rdfs:comment |
Louis Anthony Tartaglia is an American bio … Louis Anthony Tartaglia is an American biochemist, pharmaceutical scientist, and entrepreneur. As a scientist, he is known for first identifying and cloning the leptin receptor in 1995, a discovery that prompted immediate coverage in US national media given its expected clinical significance. He is also known for studying signaling mechanisms from the tumor necrosis factor (TNF) receptors, and for publishing studies in the fields of obesity and diabetes which are often discussed in subject reviews. After moving from academia to industry in 1990, for over a decade he accompanied the growth of Millennium Pharmaceuticals, reaching top positions within the company. From executive roles he has occupied in venture capital firms, and as a member of several advisory boards, Tartaglia has helped stl advisory boards, Tartaglia has helped st
|
| rdfs:label |
Louis Tartaglia
|
